FREEMAN PENG – Trademark Portfolio

Entity Type: 16

FREEMAN PENG holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 4 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered and 2 are pending. Notable registered marks include CAROSS. The owner is based in MILLBRAE, CA.

863 Pinon Ave.

MILLBRAE, CA 94030

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SENRIDA
SENRIDA
Pending 2026
AVENZA
AVENZA
Pending 2026
CAROSS
CAROSS
Registered 2025

Trademark Classifications

FREEMAN PENG's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (4 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does FREEMAN PENG have?

FREEMAN PENG has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 pending, 1 abandoned.

What trademark classes does FREEMAN PENG file in?

FREEMAN PENG files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are FREEMAN PENG's most well-known trademarks?

FREEMAN PENG's registered trademark portfolio includes well-known marks such as CAROSS. These are among 1 currently registered trademark in the portfolio.

What is FREEMAN PENG's trademark registration success rate?

FREEMAN PENG has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 2 applications are pending review.